A functional +61G/A polymorphism in epidermal growth factor is associated with Glioma risk among asians

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Xu, Xin ^a   Xi, Lei ^a   Zeng, Jie ^a   Yao, Qinhong ^a  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EPIDERMAL GROWTH FACTOR; GLYCINE;

ARTICLE; ASIAN; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CAUCASIAN; EGF GENE; ETHNIC DIFFERENCE; ETHNICITY; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GLIOMA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; EPIDERMAL GROWTH FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84864075542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041470     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
3. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, et al. (2001) Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93: 1553-1557.
4. Normanno N, Bianco C, De Luca A, Salomon DS, (2001) The role of EGF-related peptides in tumor growth. Front Biosci 6: D685-707.
5. Laurence DJ, Gusterson BA, (1990) The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumour Biol 11: 229-261.
6. Fenstermaker RA, Ciesielski MJ, (2000) Deletion and tandem duplication of exons 2-7 in the epidermal growth factor receptor gene of a human malignant glioma. Oncogene 19: 4542-4548.
7. Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG, (1996) Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 148: 1047-1053.
8. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, et al. (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359: 397-401.
9. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ, (2004) A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64: 1220-1223.
10. Xu W, Li Y, Wang X, Chen B, Liu S, et al. (2010) Association between EGF promoter polymorphisms and cancer risk: a meta-analysis. Med Oncol 27: 1389-1397.
11. Zhang YM, Cao C, Liang K, (2010) Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epidemiol 34: 150-156.
12. Handoll HH, (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87: 875.
13. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
14. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
15. Ramos-Corpas D, Santiago JC, (2006) Single large study or meta-analysis parameters: choosing the most appropriate tool for Down syndrome screening in the first trimester. Prenat Diagn 26: 1124-1130.
16. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
17. Bao G, Wang M, Guo S, Han Y, Xu G, (2010) Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population. J Int Med Res 38: 1645-1652.
18. Wang S, Zhao Y, Ruan Z, Chen H, Fan W, et al. (2010) Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer 10: 221.
19. Liu X, Li L, Chen X, Wang X, Mu L, et al. (2009) No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers 24: 77-82.
20. Pinto GR, Yoshioka FK, Clara CA, Santos MJ, Almeida JR, et al. (2009) Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers 24: 277-281.
21. Vauleon E, Auger N, Benouaich-Amiel A, Laigle-Donadey F, Kaloshi G, et al. (2007) The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 172: 33-37.
22. Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, et al. (2007) Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res 13: 2621-2626.
23. Mullhaupt B, Feren A, Jones A, Fodor E, (2000) DNA sequence and functional characterization of the human and rat epidermal growth factor promoter: regulation by cell growth. Gene 250: 191-200.
24. Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, et al. (2005) The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets 6: 243-257.
25. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K, (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.
26. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
27. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
28. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
29. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, et al. (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100: 962-966.